Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
Marilyn Yuanxin Ma Bui, MD, PhD
Anne Vincent-Salomon, MD
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Vera Bril, MD
Hans Katzberg, MD
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
Nicholas J. Silvestri, MD
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
April 29, 2025
San Diego, California
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
May 01, 2025
Washington, DC, District of Columbia
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
Mazen Noureddin, MD, MHSc
What’s New in Glaucoma Topical Therapies?
Justin Schweitzer, OD, FAAO
Sarah H. Van Tassel, MD
What’s New in Subconjunctival MIBS
Paul Petrakos, DO, MS
I. Paul Singh, MD
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Jonathan Strober, MD
Diagnostic Advances in gMG: Effective Tools and Techniques
Managing Side Effects in FcRn Therapy: Best Practices for gMG
What’s New With 3D Visualization in Glaucoma Surgery?
What’s New in Glaucoma Therapy?
Ocular to Generalized MG: How and Why the Disease Evolves
New Solutions for Optimizing IOP Control: A Case-Based Approach
What’s New in Suprachoroidal MIGS?
3D Heads-Up Visualization: Cases in Glaucoma Surgery
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
Sandra Swain, MD
Virginia Kaklamani, MD
Timing of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.